| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.8 | 0.004 | 0.8 | Aldehyde oxidase inhibitor | 0.536 0.028 CID_38989112 | ||
| 0.569 | 0.001 | 0.569 | Histamine N-methyltransferase inhibitor | 0.416 0.002 CID_38989112 | ||
| 0.505 | 0.058 | 0.505 | Caspase 9 stimulant | 0.324 0.169 CID_38989112 | ||
| 0.401 | 0.002 | 0.44 | Botulinum neurotoxin type A inhibitor | 0.44 0.002 CID_38989112 | CID_38989112 | |
| 0.337 | 0.028 | 0.337 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.261 0.055 CID_38989112 | ||
| 0.318 | 0.013 | 0.318 | Nav1.2 sodium channel blocker | 0.191 0.038 CID_38989112 | ||
| 0.318 | 0.042 | 0.318 | Amyloid beta aggregation inhibitor | 0.25 0.058 CID_38989112 | ||
| 0.336 | 0.06 | 0.659 | 5 Hydroxytryptamine release stimulant | 0.659 0.01 CID_38989112 | CID_38989112 | |
| 0.314 | 0.048 | 0.314 | Antiamyloidogenic | 0.269 0.063 CID_38989112 | ||
| 0.358 | 0.096 | 0.358 | Histamine release inhibitor | 0.213 0.187 CID_38989112 | ||
| 0.315 | 0.054 | 0.315 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.27 0.088 CID_38989112 | ||
| 0.319 | 0.063 | 0.319 | Spasmolytic | 0.197 0.123 CID_38989112 | ||
| 0.293 | 0.04 | 0.293 | Sigma receptor agonist | |||
| 0.258 | 0.012 | 0.258 | ATPase inhibitor | 0.204 0.034 CID_38989112 | ||
| 0.244 | 0.01 | 0.244 | Nav1.6 sodium channel blocker | 0.171 0.034 CID_38989112 | ||
| 0.348 | 0.117 | 0.348 | 5 Hydroxytryptamine release inhibitor | 0.248 0.23 CID_38989112 | ||
| 0.275 | 0.05 | 0.275 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.181 0.087 CID_38989112 | ||
| 0.325 | 0.1 | 0.338 | GABA C receptor rho-3 antagonist | 0.338 0.092 CID_38989112 | CID_38989112 | |
| 0.274 | 0.05 | 0.303 | Psychostimulant | 0.303 0.042 CID_38989112 | CID_38989112 | |
| 0.277 | 0.058 | 0.332 | 5 Hydroxytryptamine uptake stimulant | 0.332 0.031 CID_38989112 | CID_38989112 | |
| 0.28 | 0.065 | 0.28 | Cardiotonic | 0.169 0.153 CID_38989112 | ||
| 0.269 | 0.058 | 0.269 | Potassium channel blocker | 0.158 0.128 CID_38989112 | ||
| 0.265 | 0.066 | 0.265 | Superoxide dismutase inhibitor | 0.253 0.073 CID_38989112 | ||
| 0.218 | 0.019 | 0.218 | Nav1.3 sodium channel blocker | 0.206 0.022 CID_38989112 | ||
| 0.251 | 0.055 | 0.251 | Neuropeptide Y2 antagonist | 0.213 0.098 CID_38989112 | ||
| 0.201 | 0.01 | 0.201 | NADH dehydrogenase inhibitor | 0.107 0.037 CID_38989112 | ||
| 0.225 | 0.039 | 0.225 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.139 0.072 CID_38989112 | ||
| 0.207 | 0.022 | 0.207 | Alpha 2b adrenoreceptor antagonist | 0.187 0.027 CID_38989112 | ||
| 0.204 | 0.021 | 0.204 | Butyrylcholinesterase inhibitor | 0.148 0.035 CID_38989112 | ||
| 0.225 | 0.063 | 0.225 | DNA methylase inhibitor | 0.155 0.113 CID_38989112 | ||
| 0.208 | 0.06 | 0.208 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.122 0.114 CID_38989112 | ||
| 0.176 | 0.033 | 0.176 | DNA intercalator | 0.133 0.051 CID_38989112 | ||
| 0.165 | 0.031 | 0.165 | Chelator | 0.139 0.04 CID_38989112 | ||
| 0.152 | 0.02 | 0.152 | Telomerase inhibitor | 0.103 0.032 CID_38989112 | ||
| 0.187 | 0.055 | 0.187 | Protein kinase (CK1) gamma 3 inhibitor | 0.145 0.096 CID_38989112 | ||
| 0.137 | 0.006 | 0.137 | Potassium channel (ATP-sensitive) blocker | 0.099 0.016 CID_38989112 | ||
| 0.182 | 0.051 | 0.182 | Death-associated protein kinase 2 inhibitor | 0.149 0.109 CID_38989112 | ||
| 0.173 | 0.043 | 0.173 | Acetylcholinesterase inhibitor | 0.121 0.077 CID_38989112 | ||
| 0.257 | 0.127 | 0.257 | Vasodilator, coronary | 0.238 0.147 CID_38989112 | ||
| 0.145 | 0.033 | 0.145 | Falcipain inhibitor | 0.136 0.037 CID_38989112 | ||
| 0.115 | 0.005 | 0.115 | Corticotropin releasing factor 2 receptor antagonist | 0.107 0.005 CID_38989112 | ||
| 0.113 | 0.004 | 0.113 | CC chemokine 4 receptor antagonist | 0.078 0.008 CID_38989112 | ||
| 0.185 | 0.077 | 0.185 | DNA methyltransferase I inhibitor | |||
| 0.14 | 0.033 | 0.14 | Falcipain 2 inhibitor | 0.129 0.038 CID_38989112 | ||
| 0.193 | 0.088 | 0.193 | Anticonvulsant | 0.145 0.136 CID_38989112 | ||
| 0.166 | 0.065 | 0.166 | Cholinergic | |||
| 0.15 | 0.051 | 0.175 | Glutamate receptor antagonist | 0.175 0.035 CID_38989112 | CID_38989112 | |
| 0.162 | 0.064 | 0.162 | Acetylcholine M1 receptor antagonist | 0.133 0.092 CID_38989112 | ||
| 0.133 | 0.04 | 0.133 | Nav1.1 sodium channel blocker | |||
| 0.124 | 0.033 | 0.124 | Electrolyte absorption antagonist | |||
| 0.196 | 0.105 | 0.251 | Peptidyltransferase inhibitor | 0.251 0.05 CID_38989112 | CID_38989112 | |
| 0.243 | 0.155 | 0.243 | Calcium channel activator | |||
| 0.098 | 0.01 | 0.098 | Potassium channel (Ca-activated) blocker | 0.076 0.021 CID_38989112 | ||
| 0.178 | 0.097 | 0.178 | Interleukin antagonist | 0.177 0.099 CID_38989112 | ||
| 0.148 | 0.068 | 0.19 | Neuropeptide Y1 antagonist | 0.19 0.023 CID_38989112 | CID_38989112 | |
| 0.084 | 0.009 | 0.084 | Potassium channel small-conductance Ca-activated blocker | 0.056 0.02 CID_38989112 | ||
| 0.182 | 0.112 | 0.182 | ErbB-1 antagonist | |||
| 0.189 | 0.125 | 0.189 | DNA damaging | 0.186 0.128 CID_38989112 | ||
| 0.166 | 0.105 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.139 0.131 CID_38989112 | ||
| 0.115 | 0.054 | 0.115 | Alpha 2c adrenoreceptor antagonist | 0.103 0.063 CID_38989112 | ||
| 0.152 | 0.091 | 0.152 | Cyclin-dependent kinase 3 inhibitor | 0.145 0.108 CID_38989112 | ||
| 0.068 | 0.008 | 0.068 | Benzodiazepine antagonist | 0.049 0.028 CID_38989112 | ||
| 0.119 | 0.063 | 0.119 | Interleukin 8 antagonist | 0.107 0.082 CID_38989112 | ||
| 0.065 | 0.01 | 0.065 | Plasmepsin II inhibitor | 0.049 0.019 CID_38989112 | ||
| 0.136 | 0.085 | 0.136 | Thiol protease inhibitor | 0.131 0.095 CID_38989112 | ||
| 0.112 | 0.062 | 0.112 | Acetylcholine release stimulant | |||
| 0.107 | 0.056 | 0.119 | Factor V inhibitor | 0.119 0.039 CID_38989112 | CID_38989112 | |
| 0.098 | 0.048 | 0.127 | NMDA receptor antagonist | 0.127 0.032 CID_38989112 | CID_38989112 | |
| 0.07 | 0.02 | 0.07 | Bcl-xL inhibitor | 0.061 0.037 CID_38989112 | ||
| 0.158 | 0.111 | 0.158 | Death-associated protein kinase 3 inhibitor | 0.147 0.127 CID_38989112 | ||
| 0.168 | 0.122 | 0.168 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.112 | 0.067 | 0.131 | CDK3/cyclin E inhibitor | 0.131 0.042 CID_38989112 | CID_38989112 | |
| 0.149 | 0.105 | 0.191 | Neurotensin receptor agonist | 0.191 0.04 CID_38989112 | CID_38989112 | |
| 0.179 | 0.136 | 0.243 | Calpain inhibitor | 0.243 0.071 CID_38989112 | CID_38989112 | |
| 0.061 | 0.023 | 0.061 | Potassium channel (Inward rectifier) blocker | |||
| 0.134 | 0.097 | 0.134 | MAP kinase 3 inhibitor | |||
| 0.07 | 0.033 | 0.07 | NMDA 2C receptor antagonist | 0.056 0.051 CID_38989112 | ||
| 0.059 | 0.022 | 0.07 | Potassium channel (Inward rectifier) activator | 0.07 0.012 CID_38989112 | CID_38989112 | |
| 0.05 | 0.013 | 0.05 | Cathepsin F inhibitor | 0.047 0.016 CID_38989112 | ||
| 0.097 | 0.061 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.067 | 0.031 | 0.075 | Heat shock protein 90 beta antagonist | 0.075 0.024 CID_38989112 | CID_38989112 | |
| 0.056 | 0.02 | 0.067 | Potassium channel (ATP-sensitive) activator | 0.067 0.011 CID_38989112 | CID_38989112 | |
| 0.126 | 0.092 | 0.126 | Aurora-C kinase inhibitor | 0.12 0.106 CID_38989112 | ||
| 0.212 | 0.177 | 0.293 | Calpain 2 inhibitor | 0.293 0.119 CID_38989112 | CID_38989112 | |
| 0.197 | 0.162 | 0.197 | Insulysin inhibitor | 0.189 0.175 CID_38989112 | ||
| 0.201 | 0.168 | 0.201 | Caspase 3 stimulant | |||
| 0.093 | 0.061 | 0.106 | Protein kinase C zeta inhibitor | 0.106 0.043 CID_38989112 | CID_38989112 | |
| 0.095 | 0.064 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | 0.105 0.052 CID_38989112 | CID_38989112 | |
| 0.042 | 0.012 | 0.042 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.182 | 0.152 | 0.182 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.085 | 0.057 | 0.092 | Myeloperoxidase inhibitor | 0.092 0.046 CID_38989112 | CID_38989112 | |
| 0.138 | 0.111 | 0.138 | LIM domain kinase 1 inhibitor | 0.131 0.119 CID_38989112 | ||
| 0.064 | 0.039 | 0.064 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.104 | 0.079 | 0.104 | Interleukin 2 antagonist | |||
| 0.044 | 0.02 | 0.044 | Growth hormone secretagogue receptor antagonist | |||
| 0.052 | 0.03 | 0.052 | Topoisomerase II beta inhibitor | |||
| 0.046 | 0.026 | 0.066 | Histamine H1 receptor agonist | 0.066 0.005 CID_38989112 | CID_38989112 | |
| 0.077 | 0.058 | 0.077 | Acetylcholine nicotinic antagonist | |||
| 0.086 | 0.068 | 0.086 | Potassium channel (Ca-activated) activator | |||
| 0.058 | 0.04 | 0.058 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.119 | 0.101 | 0.119 | Peroxidase inhibitor | |||
| 0.04 | 0.022 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 CID_38989112 | CID_38989112 | |
| 0.114 | 0.096 | 0.118 | Cytokine production inhibitor | 0.118 0.091 CID_38989112 | CID_38989112 | |
| 0.058 | 0.041 | 0.116 | Glutamate (mGluR1) antagonist | 0.116 0.012 CID_38989112 | CID_38989112 | |
| 0.03 | 0.014 | 0.03 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.103 | 0.087 | 0.103 | Acetylcholine muscarinic antagonist | |||
| 0.093 | 0.079 | 0.108 | Folate antagonist | 0.108 0.052 CID_38989112 | CID_38989112 | |
| 0.033 | 0.02 | 0.033 | GHS receptor antagonist | |||
| 0.128 | 0.115 | 0.18 | Heat shock protein 90 alpha antagonist | 0.18 0.062 CID_38989112 | CID_38989112 | |
| 0.075 | 0.062 | 0.075 | Viral attachment inhibitor | |||
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.097 | 0.085 | 0.097 | Anesthetic local | |||
| 0.104 | 0.092 | 0.104 | MAP kinase 12 inhibitor | |||
| 0.102 | 0.093 | 0.102 | Cholinergic antagonist | |||
| 0.036 | 0.027 | 0.036 | Factor XIIIa inhibitor | |||
| 0.124 | 0.116 | 0.124 | Pregnane X receptor agonist | |||
| 0.068 | 0.06 | 0.068 | Acetylcholine M4 receptor antagonist | |||
| 0.018 | 0.012 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.012 CID_38989112 | CID_38989112 | |
| 0.022 | 0.016 | 0.022 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.099 | 0.093 | 0.099 | Acetylcholine antagonist | |||
| 0.04 | 0.035 | 0.04 | NMDA receptor subunit 3B antagonist | |||
| 0.08 | 0.075 | 0.092 | Potassium channel activator | 0.092 0.057 CID_38989112 | CID_38989112 | |
| 0.059 | 0.056 | 0.059 | Bcl2 antagonist | |||
| 0.051 | 0.05 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 CID_38989112 | CID_38989112 | |
| 0.097 | 0.097 | 0.101 | Cell adhesion inhibitor | 0.101 0.087 CID_38989112 | CID_38989112 | |
| 0.106 | 0.11 | 0.169 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 CID_38989112 | CID_38989112 | |
| 0.059 | 0.064 | 0.081 | NMDA 2 receptor antagonist | 0.081 0.043 CID_38989112 | CID_38989112 | |
| 0.1 | 0.107 | 0.114 | Cathepsin H inhibitor | 0.114 0.083 CID_38989112 | CID_38989112 | |
| 0.021 | 0.029 | 0.035 | AMPA 3 receptor antagonist | 0.035 0.017 CID_38989112 | CID_38989112 | |
| 0.118 | 0.13 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.069 CID_38989112 | CID_38989112 | |
| 0.087 | 0.1 | 0.102 | Topoisomerase II inhibitor | 0.102 0.084 CID_38989112 | CID_38989112 | |
| 0.066 | 0.08 | 0.109 | Adrenaline agonist | 0.109 0.031 CID_38989112 | CID_38989112 | |
| 0.16 | 0.174 | 0.192 | 5 Hydroxytryptamine 3E antagonist | 0.192 0.076 CID_38989112 | CID_38989112 | |
| 0.049 | 0.069 | 0.066 | NMDA receptor agonist | 0.066 0.039 CID_38989112 | CID_38989112 | |
| 0.111 | 0.132 | 0.138 | Heat shock protein 90 antagonist | 0.138 0.087 CID_38989112 | CID_38989112 | |
| 0.023 | 0.05 | 0.042 | Complement C3a chemotactic receptor antagonist | 0.042 0.031 CID_38989112 | CID_38989112 | |
| 0.068 | 0.095 | 0.077 | Histamine H2 receptor antagonist | 0.077 0.071 CID_38989112 | CID_38989112 | |
| 0.076 | 0.105 | 0.1 | Nitric-oxide synthase inhibitor | 0.1 0.06 CID_38989112 | CID_38989112 | |
| 0.064 | 0.096 | 0.073 | Neuropeptide Y antagonist | 0.073 0.071 CID_38989112 | CID_38989112 | |
| 0.039 | 0.071 | 0.063 | Myc inhibitor | 0.063 0.026 CID_38989112 | CID_38989112 | |
| 0.029 | 0.062 | 0.052 | NMDA 2A receptor antagonist | 0.052 0.036 CID_38989112 | CID_38989112 | |
| 0.081 | 0.115 | 0.134 | Histone deacetylase class III inhibitor | 0.134 0.058 CID_38989112 | CID_38989112 | |
| 0.053 | 0.087 | 0.06 | Beta 2 adrenoreceptor agonist | 0.06 0.05 CID_38989112 | CID_38989112 | |
| 0.074 | 0.118 | 0.084 | Glutamate release inhibitor | 0.084 0.077 CID_38989112 | CID_38989112 | |
| 0.015 | 0.061 | 0.031 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.022 CID_38989112 | CID_38989112 | |
| 0.056 | 0.106 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.034 CID_38989112 | CID_38989112 | |
| 0.058 | 0.112 | 0.072 | Vanilloid 4 agonist | 0.072 0.059 CID_38989112 | CID_38989112 | |
| 0.033 | 0.099 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.042 CID_38989112 | CID_38989112 | |
| 0.047 | 0.122 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.054 CID_38989112 | CID_38989112 | |
| 0.028 | 0.11 | 0.052 | Histamine agonist | 0.052 0.037 CID_38989112 | CID_38989112 | |
| 0.04 | 0.122 | 0.065 | Sirtuin 1 inhibitor | 0.065 0.051 CID_38989112 | CID_38989112 | |
| 0.012 | 0.095 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | 0.031 0.027 CID_38989112 | CID_38989112 | |
| 0.063 | 0.149 | 0.097 | GABA C receptor rho-1 antagonist | 0.097 0.067 CID_38989112 | CID_38989112 | |
| 0.073 | 0.17 | 0.128 | Thrombolytic | 0.128 0.101 CID_38989112 | CID_38989112 | |
| 0.162 | 0.266 | 0.197 | Interleukin 2 agonist | 0.197 0.194 CID_38989112 | CID_38989112 | |
| 0.032 | 0.162 | 0.082 | DNA gyrase inhibitor | 0.082 0.026 CID_38989112 | CID_38989112 | |
| 0.072 | 0.275 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 CID_38989112 | CID_38989112 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |